Aurigene Pharmaceutical Services and Alveus Therapeutics announce research collaboration
Aurigene provides AI-enabled integrated drug discovery services supporting Alveus鈥� research programs in obesity and metabolic disease.
Dr. Reddy's
Dr. Reddy鈥檚 launches first-to-market OTC generic of extra-strength Pataday in U.S.
鈥淭he first-to-market launch underscores our capabilities in bringing store-brand equivalents of leading OTC brands to the U.S. market.鈥�
Extrovis AG and Dr. Reddy鈥檚 announce the launch of the authorized generic of Carac
Manufactured in Texas at one of Extrovis鈥� facilities, Dr. Reddy鈥檚 Fluorouracil Cream, 0.5%, is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp.
Dr. Reddy鈥檚 debuts larger size Doan鈥檚
鈥淲e are pleased to launch the 100-count 鈥� we know back pain affects many adults of all ages,鈥� said Kathryn Healy, head of marketing for Doan鈥檚 for manufacturer Dr. Reddy鈥檚.
Q&A: Girotra on Dr. Reddy鈥檚 branded O-T-C focus
Girota鈥檚 role involves shaping the strategic road map and scaling the business with the aspiration to establish Dr. Reddy鈥檚 as a leading player in the consumer health segment
Alvotech and Dr. Reddy鈥檚 working to co-develop biosimilar candidate to Keytruda (pembrolizumab)
The collaboration combines Dr. Reddy鈥檚 and Alvotech鈥檚 proven capabilities in biosimilars, thus, speeding up the development process and extending the global reach for this biosimilar candidate.
Dr. Reddy's named by Science Magazine in top 20 global pharma employers list
This marks the third consecutive appearance of Dr. Reddy鈥檚 in the list.